Toshihiko Serikawa
- Co-authors
- Shoki NishidaShinichi NakamuraKiyotaka YamakawaSatoshi NakashioSeiichi OkumuraTakayoshi YamagishiGenji SakaguchiShunji Kozaki
- Topics
- Botulinum Toxin and Related Neurological Disorders (6 papers)Clostridium difficile and Clostridium perfringens research (6 papers)Gut microbiota and health (3 papers)
- Partner nations
- Japan
In The Last Decade
Toshihiko Serikawa
12 papers receiving 298 citations
Peers
Comparison fields: 5 of 41
- Infectious Diseases 263
- Molecular Biology 96
- Epidemiology 96
- Neurology 49
- Food Science 36
Countries citing papers authored by Toshihiko Serikawa
This map shows the geographic impact of Toshihiko Serikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshihiko Serikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshihiko Serikawa more than expected).
Fields of papers citing papers by Toshihiko Serikawa
This network shows the impact of papers produced by Toshihiko Serikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshihiko Serikawa. The network helps show where Toshihiko Serikawa may publish in the future.
Co-authorship network of co-authors of Toshihiko Serikawa
This figure shows the co-authorship network connecting the top 25 collaborators of Toshihiko Serikawa. A scholar is included among the top collaborators of Toshihiko Serikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshihiko Serikawa. Toshihiko Serikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 23 | |
| 2 | Genotyping of Clostridium perfringens isolates collected from food poisoning outbreaks and healthy individuals in Japan based on the cpe locus. | 26 |
| 3 | 16 | |
| 4 | 20 | |
| 5 | 24 | |
| 6 | 122 | |
| 7 | C2 toxin production by Clostridium botulinum type C strains producing no C1 toxin. | 1 |
| 8 | 32 | |
| 9 | 13 | |
| 10 | 35 | |
| 11 | [Clostridium sporogenes-like strains derived from canned food]. | 2 |
| 12 | 10 |
About Toshihiko Serikawa
Toshihiko Serikawa is a scholar working on Neurology, Endocrinology and Infectious Diseases, having authored 12 papers that have together received 324 indexed citations. Recurring topics across this work include Botulinum Toxin and Related Neurological Disorders (6 papers), Clostridium difficile and Clostridium perfringens research (6 papers) and Gut microbiota and health (3 papers). The work is most often cited by research in Infectious Diseases (263 citations), Critical Care and Intensive Care Medicine (35 citations) and Endocrinology (34 citations). Toshihiko Serikawa has collaborated with scholars based in Japan. Frequent co-authors include Shoki Nishida, Shinichi Nakamura, Kiyotaka Yamakawa, Satoshi Nakashio, Seiichi Okumura, Takayoshi Yamagishi, Genji Sakaguchi, Shunji Kozaki, Yoshiyuki Nagai and Reiji Hiramatsu. Their work appears in journals such as Microbiology and Immunology, Japanese Journal of Infectious Diseases and Kansenshogaku zasshi.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.